Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trial.
von Groote T, Meersch M, Romagnoli S, Ostermann M, Ripollés-Melchor J, Schneider AG, Vandenberghe W, Monard C, De Rosa S, Cattin L, Rahmel T, Adamzik M, Parise D, Candela-Toha A, Haaker JG, Göbel U, Bernard A, Lumlertgul N, Fernández-Valdes-Bango P, Romero Bhathal I, Suarez-de-la-Rica A, Larmann J, Villa G, Spadaro S, Wulf H, Arndt C, Putensen C, García-Álvarez R, Brandenburger T, Siniscalchi A, Ellerkmann R, Espeter F, Porschen C, Sadjadi M, Saadat-Gilani K, Weiss R, Gerss J, Kellum J, Zarbock A; BigpAK-2 Investigators. von Groote T, et al. Among authors: siniscalchi a. BMJ Open. 2023 Mar 27;13(3):e070240. doi: 10.1136/bmjopen-2022-070240. BMJ Open. 2023. PMID: 36972972 Free PMC article.
Removal of Bilirubin with a New Adsorbent System: In Vitro Kinetics.
Gemelli C, Cuoghi A, Magnani S, Atti M, Ricci D, Siniscalchi A, Mancini E, Faenza S. Gemelli C, et al. Among authors: siniscalchi a. Blood Purif. 2019;47(1-3):10-15. doi: 10.1159/000492378. Epub 2018 Sep 14. Blood Purif. 2019. PMID: 30219813
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections.
Gatti M, Cojutti PG, Pascale R, Tonetti T, Laici C, Dell'Olio A, Siniscalchi A, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: siniscalchi a. Antibiotics (Basel). 2021 Oct 27;10(11):1311. doi: 10.3390/antibiotics10111311. Antibiotics (Basel). 2021. PMID: 34827249 Free PMC article.
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization.
Cojutti PG, Gatti M, Rinaldi M, Tonetti T, Laici C, Mega C, Siniscalchi A, Giannella M, Viale P, Pea F. Cojutti PG, et al. Among authors: siniscalchi a. Front Pharmacol. 2021 Dec 8;12:781892. doi: 10.3389/fphar.2021.781892. eCollection 2021. Front Pharmacol. 2021. PMID: 34955851 Free PMC article.
Predictive factors of inhospital mortality for ICU patients with acute-on-chronic liver failure undergoing liver transplantation.
Laici C, Guizzardi C, Morelli MC, Vitale G, Caraceni P, Cescon M, Ravaioli M, Bacchi Reggiani ML, Baldassarre M, Siniscalchi A. Laici C, et al. Among authors: siniscalchi a. Eur J Gastroenterol Hepatol. 2022 Sep 1;34(9):967-974. doi: 10.1097/MEG.0000000000002413. Epub 2022 Jul 27. Eur J Gastroenterol Hepatol. 2022. PMID: 35913780
352 results